Rossana Domenis

Udine, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Liver Gene Therapy in Fabry Disease Mice With Low Doses of rAAV2/8 Expressing a Codon-Optimized hGLA cDNA Results in Long-Term Disease Correction.

Liver Gene Therapy in Fabry Disease Mice With Low Doses of rAAV2/8 Expressing a Codon-Optimized hGLA cDNA Results in Long-Term Disease Correction.

Journal: Journal of inherited metabolic disease

Published: November 24, 2025

Iatrogenic NORSE: Immune checkpoint inhibitor-related anti-GFAP autoimmune astrocytopathy.

Iatrogenic NORSE: Immune checkpoint inhibitor-related anti-GFAP autoimmune astrocytopathy.

Journal: Journal of neuroimmunology

Published: September 01, 2025

Prediction, prevention, and precision treatment of immune checkpoint inhibitor neurological toxicity using autoantibodies, cytokines, and microbiota.

Prediction, prevention, and precision treatment of immune checkpoint inhibitor neurological toxicity using autoantibodies, cytokines, and microbiota.

Journal: Frontiers in immunology

Published: December 20, 2024

Brain Endothelial Cells Activate Neuroinflammatory Pathways in Response to Early Cerebral Small Vessel Disease (CSVD) Patients' Plasma.

Brain Endothelial Cells Activate Neuroinflammatory Pathways in Response to Early Cerebral Small Vessel Disease (CSVD) Patients' Plasma.

Journal: Biomedicines

Published: October 11, 2023

Ceramide releases exosomes with a specific miRNA signature for cell differentiation.

Ceramide releases exosomes with a specific miRNA signature for cell differentiation.

Journal: Scientific reports

Published: March 13, 2023

Humoral and T-Cell Mediated Response after the Third Dose of mRNA Vaccines in Patients with Systemic Lupus Erythematosus on Belimumab.

Humoral and T-Cell Mediated Response after the Third Dose of mRNA Vaccines in Patients with Systemic Lupus Erythematosus on Belimumab.

Journal: Journal of clinical medicine

Published: December 16, 2022

Comment on: "SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response" by Verhoeven et al. Joint Bone Spine 2021;88:105258.

Comment on: "SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response" by Verhoeven et al. Joint Bone Spine 2021;88:105258.

Journal: Joint bone spine

Published: March 22, 2022

False positive high-sensitivity cardiac troponin I elevation in a newborn.

False positive high-sensitivity cardiac troponin I elevation in a newborn.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: March 02, 2022

High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients.

High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients.

Journal: Journal of autoimmunity

Published: February 08, 2022

Immune Responses against SARS-CoV-2-Questions and Experiences.

Immune Responses against SARS-CoV-2-Questions and Experiences.

Journal: Biomedicines

Published: August 24, 2021

Pro-Inflammatory Microenvironment Modulates the Transfer of Mutated TP53 Mediated by Tumor Exosomes.

Pro-Inflammatory Microenvironment Modulates the Transfer of Mutated TP53 Mediated by Tumor Exosomes.

Journal: International journal of molecular sciences

Published: May 04, 2021

Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia.

Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia.

Journal: Cytokine

Published: November 07, 2020

Showing 1-12 of 34

Last Updated: 09/26/2026